DIAGNOSTIC TEST 205

Envoplakin Antibodies (IgG)

Diagnostic test for antibodies against Envoplakin (IgG). For suspicion of paraneoplastic pemphigus (PNP).

Indication

Suspicion of paraneoplastic pemphigus

Sample material

Serum

  • Minim. volume: 0,5 mL

Transport

  • Within Sweden: room temperature
  • International: cold

Method

ELISA

Reference interval

<1.0 negative

Result

Results are reported as negative or positive with a ratio.

Interpretation

Anti-envoplakin (IgG) antibodies occur in PNP (paraneoplastic pemphigus) association with lymphoproliferative diseases like non-Hodgkins’s lymphoma and CLL (chronic lymphocytic leukemia). Antibody concentration correlates with disease activity and may be used to monitor treatment efficacy.

References

  • Baum S et al. Autoimmun Rev. 2014. Diagnosis and classification of autoimmune blistering diseases. PMID: 24434358
  • Garbanzos CCT et al. J Cutan Pathol. 2025. Clinical, Serologic, and Histopathologic Features of Patients With Pemphigus With Either Positive or Negative IgG4 Intercellular Deposition by Direct Immunofluorescence (DIF): A Retrospective Case-Control Study of 55 DIF Biopsy Specimens. PMID: 40555471
  • van Beek N et al. Front Immunol. 2024. State-of-the-art diagnosis of autoimmune blistering diseases. PMID: 38903493

Included in these panels

Need pricing information?

How to order

This test is only available as part of a test panel.

Last updated: 2026-09-14